Table 1.

Demographic and baseline disease characteristics of patients: full analysis set

Number of patients (%)
Part A, n = 30Part B, n = 29
Sex
    Male20 (66.7)13 (44.8)
    Female10 (33.3)16 (55.2)
Age (y)
    Mean (SD)57.9 (10.9)57.1 (13.5)
    Range30-7626-9
Racial origin
    Caucasian30 (100.0)27 (93.1)
    Black0 (0)1 (3.4)
    Mixed race0 (0)1 (3.4)
WHO performance status*
    014 (46.7)11 (37.9)
    114 (46.7)16 (55.2)
    21 (3.3)1 (3.4)
    Unknown1 (3.3)1 (3.4)
Primary tumor location
    Colorectal9 (30.0)11 (37.9)
    Lung3 (10.0)2 (6.9)
    Esophagus2 (6.7)0 (0)
    Skin/soft tissue10 (33.3)4 (13.8)
    Stomach0 (0)2 (6.9)
    Pancreas0 (0)2 (6.9)
    Other0 (0)2 (6.9)
Previous treatments
    Radiotherapy10 (33.3)9 (31.0)
    Chemotherapy28 (93.3)26 (89.7)
    Immunotherapy12 (40.0)7 (24.1)
    Other13 (43.3)8 (27.6)
  • *WHO performance status: 0, normal activity; 1, restricted activity; 2, in bed ≤50% to 100% bedridden.

  • Only those primary tumor locations reported for two or more patients are shown.